Melinda M. Rottas

Discovery of 4-(5-Methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models

Christopher J. O’Donnell, Bruce N. Rogers, Brian S. Bronk et al. · Journal of Medicinal Chemistry · 2009 · 74 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Demographic diversity of participants in Pfizer sponsored clinical trials in the United States

Melinda M. Rottas, Peter F. Thadeio, Rachel N. Simons et al. · Contemporary Clinical Trials · 2021 · 51 citations · Full text

Medicine, Demography, Pharmacology +13

A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States

Mark R. Cullen, Adina R. Lemeshow, Sandra Cristina Ferreira Amaro et al. · Contemporary Clinical Trials · 2023 · 26 citations · Full text

Public Health, Population Health Sciences, Epidemiology +16